|Bid||134.72 x 800|
|Ask||134.97 x 800|
|Day's range||133.54 - 135.90|
|52-week range||117.08 - 189.07|
|Beta (5Y monthly)||0.24|
|PE ratio (TTM)||3.09|
|Earnings date||27 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||02 Jun 2022|
|1y target est||216.39|
Key Insights The considerable ownership by private equity firms in BioNTech indicates that they collectively have a...
Moderna CEO Stéphane Bancel is set to face Sen. Bernie Sanders to defend the company's fast growth and planned price hike of its COVID-19 vaccine.
Sarepta Therapeutics (SRPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.